If you bought into the Medibank Private IPO, then you've been on quite a ride. Why the share price has fluctuated to just under $2.50 is anyone's guess.
Shares
If shares follow the usual pattern, we're due for a strong finish to the year, writes Shane Oliver.
Stocklight.com says Australian IVF provider Virtus Health (ASX:VRT) offers an interesting buying opportunity.
Royal Dutch Shell released its third-quarter 2015 results, reporting a tidy operational performance within the context of a difficult operating environment.
The Invast team has been writing about banking valuations since May 2014 and we think it's not too late to sell the banks at these levels.
Australia's largest listed online auctioneer, Grays eCommerce is a tempting medium-term prospect says Greg Hoffman.
Accounting software group MYOB reported a revenue increase of 8% year-on-year to $161 million. Independent equities research firm Kalkine picked MYOB as a hot stock.
Despite the recent pullback in stocks such as the big banks and Telstra, investors who got in early have done nicely over the past few years. But what now?
Medibank Private (MPL) is expected to realise significant cost reductions over the next three to five years, so what does that mean for shareholders?
Many brokers don't allow you to buy shares in a minor's name. So how can I buy shares for my kids?
